ISearle’s health ministry said the lower number of cases of heart inflammation, mainly among young men who received Pfizer’s vaccine, was linked to their vaccination.
Pfizer has said it has not seen higher rates of the condition, known as myocarditis, than would be expected in the general population.
In Israel, 275 cases of myocarditis were reported between December 2020 and May 2021 among more than five million vaccinated people, the ministry said, revealing the findings of a study commissioned to investigate the matter. was.
Most of the patients who experienced heart inflammation did not spend more than four days in the hospital and 95 per cent of the cases were classified as mild, according to the study, which was conducted by the ministry by three teams of experts.
The study found “a possible link between men aged 16 to 30 years receiving second-dose (Pfizer’s) vaccine and the presence of myocarditis”.
According to the findings, such a relationship was seen more in men aged 16 to 19 years than in other age groups.
Pfizer said in a statement that it is aware of Israeli observations of myocarditis, noting that no causal link to its vaccine has been established.
Disclaimer: The opinions expressed within this article are the personal opinions of the author. The facts and opinions appearing in the article do not reflect the views of knews.uk and knews.uk does not assume any responsibility or liability for the same.